ID

31381

Beschrijving

Study ID: 104507 Clinical Study ID: BEX104507 Study Title: Phase II Study of Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphoma Patients who have Previously Received Rituximab Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996593 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin

Trefwoorden

Versies (2)
  1. 31-07-18 31-07-18 -
  2. 18-08-18 18-08-18 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

18 augustus 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphomas NCT00996593

Engels

Actual administered mCi Dose

1 Formulieren  
Dosimetric Dose
Beschrijving

Dosimetric Dose

Alias
UMLS CUI-1
C4019308
Date dose administered
Beschrijving

Medication dose; Date in time

Datatype

date

Alias
UMLS CUI [1,1]
C4019308
UMLS CUI [1,2]
C0011008
Actual Iodine-131 Anti-B1 Antibody dose administered
Beschrijving

iodine-131-tositumomab; Medication dose

Datatype

text

Maateenheden
  • mCi
Alias
UMLS CUI [1,1]
C0768182
UMLS CUI [1,2]
C3174092
mCi
Therapeutic Dose
Beschrijving

Therapeutic Dose

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0178602
Date Therapeutic Dose administered
Beschrijving

Date Therapeutic Dose administered

Datatype

date

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0011008
Actual Iodine-131 Anti-B1 Antibody dose administered
Beschrijving

Actual Iodine-131 Anti-B1 Antibody dose administered

Datatype

text

Maateenheden
  • mCi
Alias
UMLS CUI [1,1]
C0768182
UMLS CUI [1,2]
C3174092
mCi
Administrative
Beschrijving

Administrative

Alias
UMLS CUI-1
C1320722
Investigator Signature
Beschrijving

Investigator Signature

Datatype

text

Alias
UMLS CUI [1]
C2346576
Date of evaluation
Beschrijving

Date of evaluation

Datatype

date

Alias
UMLS CUI [1]
C2985720
Terug naar het begin van de pagina

Similar models

Actual administered mCi Dose

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Dosimetric Dose
C4019308 (UMLS CUI-1)
Medication dose; Date in time
Item
Date dose administered
date
C4019308 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
iodine-131-tositumomab; Medication dose
Item
Actual Iodine-131 Anti-B1 Antibody dose administered
text
C0768182 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
Item Group
Therapeutic Dose
C0087111 (UMLS CUI-1)
C0178602 (UMLS CUI-2)
Date Therapeutic Dose administered
Item
Date Therapeutic Dose administered
date
C0087111 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Actual Iodine-131 Anti-B1 Antibody dose administered
Item
Actual Iodine-131 Anti-B1 Antibody dose administered
text
C0768182 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
Item Group
Administrative
C1320722 (UMLS CUI-1)
Investigator Signature
Item
Investigator Signature
text
C2346576 (UMLS CUI [1])
Date of evaluation
Item
Date of evaluation
date
C2985720 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial